Cargando…

Cervical cancer screening and psychosis: a longitudinal retrospective study comparing women with schizophrenia spectrum disorders and the general population

Detalles Bibliográficos
Autores principales:	Vázquez-Bourgon, Javier, Gómez-Revuelta, Marcos, Erasun Mora, Diego, Viejo Casas, Ana, Crespo-Facorro, Benedicto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2022
Materias:	Letters to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561834/ https://www.ncbi.nlm.nih.gov/pubmed/36423346 http://dx.doi.org/10.47626/1516-4446-2022-2625

Ejemplares similares

Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program
por: Pardo-de-Santayana, Guillermo, et al.
Publicado: (2020)

Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2018)

Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2022)

A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode Psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2014)

Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2019)

T175. A 10-YEAR LONGITUDINAL STUDY OF GREY MATTER VOLUME IN FIRST EPISODE OF NON-AFFECTIVE PSYCHOSIS
por: Tordesillas-Gutiérrez, Diana, et al.
Publicado: (2018)

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2020)

F101. CANNABIS USE AND HEPATIC STEATOSIS IN PSYCHOSIS: RESULTS FROM A 3-YEAR LONGITUDINAL STUDY
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2018)

Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2020)

Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis
por: Muntané, Gerard, et al.
Publicado: (2023)

Understanding sex differences in long-term outcomes after a first episode of psychosis
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2020)

Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial
por: Garrido-Sánchez, Lucía, et al.
Publicado: (2022)

S101. DIFFERENTIATING NON-AFFECTIVE ACUTE REMITTING PSYCHOSIS (NARP) FROM SCHIZOPHRENIA IN FIRST-EPISODE PSYCHOSIS: FINDINGS FROM A 3-YEAR LONGITUDINAL STUDY IN THE PAFIP COHORT
por: López-Díaz, Álvaro, et al.
Publicado: (2020)

Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort
por: Vázquez-Bourgon, J., et al.
Publicado: (2022)

Schizophrenia Gene Expression Profile Reverted to Normal Levels by Antipsychotics
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2015)

Neuroanatomical Differences between First-Episode Psychosis Patients with and without Neurocognitive Deficit: A 3-Year Longitudinal Study
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2013)

Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study
por: Juncal-Ruiz, Maria, et al.
Publicado: (2020)

Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis
por: Pistis, Giorgio, et al.
Publicado: (2022)

Understanding the Influence of Personality Traits on Risk of Suicidal Behaviour in Schizophrenia Spectrum Disorders: A Systematic Review
por: Canal-Rivero, Manuel, et al.
Publicado: (2021)

Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2016)

Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review
por: Roiz-Santiañez, Roberto, et al.
Publicado: (2015)

Long-Term Grey Matter Changes in First Episode Psychosis: A Systematic Review
por: Gallardo-Ruiz, Ruth, et al.
Publicado: (2019)

T72. VERBAL MEMORY AND VOXEL BASED MORPHOMETRY IN FIRST EPISODE NON-AFFECTIVE PSYCHOSIS: A PROCESS ORIENTED APPROACH
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

F124. SEX DIFFERENCES IN OUTCOME IN FIRST EPISODE PSYCHOSIS PATIENTS: A 10-YEAR FOLLOW-UP STUDY
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

S124. RECOVERY TRAJECTORIES IN FIRST EPISODE PSYCHOSIS PATIENTS: THE ROLE OF TIMING
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

Apnea during slow sub-anaesthetic infusion of intravenous ketamine for treatment-resistant depression
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2020)

Childhood trauma and substance use underlying psychosis: a systematic review
por: Setién-Suero, Esther, et al.
Publicado: (2020)

Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2021)

M97. PREDICTORS OF TRANSITION TO SCHIZOPHRENIA IN BRIEF PSYCHOTIC DISORDER: FINDINGS FROM A 3-YEAR LONGITUDINAL STUDY IN THE PAFIP COHORT
por: López-Díaz, Álvaro, et al.
Publicado: (2020)

Brief greeting and shared vision()
por: Crespo-Facorro, Benedicto
Publicado: (2020)

Mental health and the SARS-CoV-2 pandemic
por: Crespo-Facorro, Benedicto
Publicado: (2020)

Mental health and the SARS-CoV-2 pandemic
por: Crespo-Facorro, Benedicto
Publicado: (2020)

F81. AGE OF ONSET OF CANNABIS USE AND COGNITIVE FUNCTION IN FIRST EPISODE NON-AFFECTIVE PSYCHOSIS PATIENTS: 3-YEAR FOLLOW-UP OUTCOME
por: Setién-Suero, Esther, et al.
Publicado: (2018)

Healthcare resource use and costs reduction with aripiprazole once-monthly in schizophrenia: AMBITION, a real-world study
por: Sanchez-Gistau, Vanessa, et al.
Publicado: (2023)

S153. WHERE IS THE ABNORMAL BRAIN ACTIVITY IN FIRST EPISODE PSYCHOSIS?
por: Pau, Soldevila-Matias, et al.
Publicado: (2018)

The right occipital lobe and poor insight in first-episode psychosis
por: Tordesillas-Gutierrez, Diana, et al.
Publicado: (2018)

Long-term mental health impact of COVID-19 on primary care health workers in northern Spain: Results from a two-phase longitudinal study
por: Viejo Casas, Ana, et al.
Publicado: (2023)

Reelin Alterations, Behavioral Phenotypes, and Brain Anomalies in Schizophrenia: A Systematic Review of Insights From Rodent Models
por: Sánchez-Hidalgo, Ana C., et al.
Publicado: (2022)

Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study
por: Canal-Rivero, Manuel, et al.
Publicado: (2023)

Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Trajectory (ENPACT) study
por: Maggioni, Eleonora, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i36p2rei6oe2e0k6hmqeqjct7b